Laura Roca-Alonso
Directeur des opérations chez E-THERAPEUTICS PLC
Profil
Laura Roca-Alonso is currently the Chief Operating & Business Officer at e-Therapeutics Plc.
Prior to this, she held the position of Director-Business Development at Gyroscope Therapeutics Ltd.
From 2004 to 2019, she served as the VP & Head-Corporate Development at Silence Therapeutics Plc.
Dr. Roca-Alonso holds a doctorate degree from Imperial College London, a graduate degree from University College London, and an undergraduate degree from Autonomous University of Barcelona.
Postes actifs de Laura Roca-Alonso
Sociétés | Poste | Début |
---|---|---|
E-THERAPEUTICS PLC | Directeur des opérations | 02/04/2020 |
Anciens postes connus de Laura Roca-Alonso
Sociétés | Poste | Fin |
---|---|---|
SILENCE THERAPEUTICS PLC | Corporate Officer/Principal | 01/01/2019 |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Laura Roca-Alonso
Imperial College London | Doctorate Degree |
Autonomous University of Barcelona | Undergraduate Degree |
University College London | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
E-THERAPEUTICS PLC | Health Technology |
SILENCE THERAPEUTICS PLC | Commercial Services |
Entreprise privées | 1 |
---|---|
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |